Ingmar Hoerr is a co-founder and former CEO of CureVac. His conversation with <em>Nature Biotechnology</em> covers his initial discovery with RNA while in his PhD program, the struggle to find venture financing for CureVac, and how a brain aneurysm changed his view on life.&nbsp; <hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

First Rounders

Nature Biotechnology

Ingmar Hoerr

FEB 1, 202263 MIN
First Rounders

Ingmar Hoerr

FEB 1, 202263 MIN

Description

Ingmar Hoerr is a co-founder and former CEO of CureVac. His conversation with <em>Nature Biotechnology</em> covers his initial discovery with RNA while in his PhD program, the struggle to find venture financing for CureVac, and how a brain aneurysm changed his view on life.&nbsp; <hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>